top of page
ABSTRACTS & POSTERS
Abstracts for AMC2024 are now available.
POSTER GALLERY
Shave Excisions in Melanoma Management: Time to re-think the guidelines?
G.Gonzalez Matheus, J.Muir
Prognostic Value of Eosinophil-to-Neutrophil Ratio in Stage IV Melanoma
M.Maddula, I.Pires da Silva, A.M.Joshua, M.Carlino, J.Wei
Immunotherapy in patients with end-stage renal failure : Case of a patient with metastatic melanoma dialyzed during immunotherapy
C.Rezzag Mahcene
Inoperable stage III melanoma efficiacy of anti-PD1 immunotherapy
C.Rezzag Mahcene
Statins and Progression of Coronary Atherosclerosis in
Melanoma Patients Treated with Immune Checkpoint
Inhibitors (SOCRATES): Progress and Updates
S.Tan, G. McArthur, S.J.Nicholls
Medicolegal considerations in the referral of patients with suspected melanoma
N.Muller, S.Tan, N. Vipulaguna, H.P.Soyer, B.De Ambrosis
Correlation of the clinical, dermatoscopic, confocal images and histopathology features of a hypomelanotic invasive melanoma with a maximum in vivo diameter of 4.0 mm
S.Beale, K.Merrick, J.Pyne, S.Clark
Immunotherapy at-home for a Patient with a Nomadic Lifestyle: A Case Study in Flexible Cancer Treatment Delivery
L.Cook, S.Murray, J.Adams
Attitudes Towards The Use Of Artificial Intelligence In Dermatology: A Survey Of Australian Dermatologists
B.Partridge, M.Janda,N.Gillespie, C.Silva, C.Arnold, L.Abbott, T.Caccetta, H.P.Soyer
The association between melanoma Breslow thickness and long-term patient survival: an Australian population-based analysis
S.Lo, G. Williams, A.E.Cust, A.H.R.Varey, S.Ch'ng, R.A.Scolyer, J.F.Thompson
Predictive Performance of the Clinicopathologic Gene Expression Profile (CP-GEP) in Identifying Cutaneous Melanoma Patients for Whom Sentinel Lymph Node Biopsy is Unnecessary: A Systematic Review and Meta-Analysis
T. Wong, P. Ferguson, L. Martin, A.M. Menzies, A. Cust, I. Silva, G. Long, R.A. Scolyer, A.C.J van Akkooi, S. Lo
MicroRNA-1246 as a potential biomarker for the detection of brain metastasis in melanoma patients
D. Sexauer, R. Difenbach, A. Stewart, W.Y. Chan, A.L. Reid, J.H. Lee, L. Warburton, L.M. Pinnel, R. Auzins, P. Zaenker, A.M. Menzies, R.A. Scolyer, G.V. Long, A.B. Beasley, E.S. Gray, H. Rizos.
Addressing the Supportive Care Needs of Melanoma Patients in Primary Care
C. Gore, L. Gomes, J. Thompson
Size Matters: Integrating Tumor Volume and IFNγ Transcriptome Signature Predicts Response to Combination Immune Checkpoint Blockade
S.Y. Lim, J.H. Lee, A. M. Menzies, M.S. Carlino, R.A. Scolyer, G.V. Long, H.Rizos
Tebentafusp and cytokine release syndrome incidence: A case series of real-world data at two hospitals
L. Roth, M. Ryan, V. Atkinson
Oncoplastic surgery for cutaneous head and neck cancers – combining reconstructive and oncologic principles to maximise outcomes
C.A. Gjorup, M. Chae, T. Wong, D. Coker, T. E. Pennington
Correlation of ctDNA with organ- and bone-specific radiographic imaging features derived from 18F-FDG PET/CT for patients with metastatic melanoma treated with immunotherapy
M. Dell’Oro, O. Lokre, T. Perk, E.S. Gray, M.A. Ebert, R.J. Francis, M. Millward
Uveal Melanoma in Solid Organ Transplant Recipients
A. Tseng, L. McGrath, N. Hayward, J. Palmer, K. Khosrotehrani
CHK1 inhibitor combination induces multiple cell death forms in melanomas and modifies the tumour immune microenvironment
Z. Zeng, S. Ong, M. Proctor, J. Gonzalez Cruz, K. Irvine, R. Dolcetti, J.W. Wells, B. Gabrielli
Prognostic and clinical impact of sentinel lymph node biopsy in Merkel cell carcinoma – a systematic review of the literature
D. Oh, M. Wu, R. Saw
A nurse’s role in supporting patients experiencing inequities and complexities of a rare melanoma
E. Zurawel
Evaluation of clinical outcomes and pattern of recurrence in patients with cutaneous melanoma and sentinel lymph node positivity who received adjuvant immunotherapy since publication of the MSLT-2 trial
E. Mor, S. Apte, K. Broman, T. Hieken, R. Bagge, R.S. Berman, A.Y. Lee, J.S. Zager, A. Kuijpers, D.W. Ollila, A.C.J. van Akkooi, D.E. Gyorki
Biodegradable Temporising Matrix (BTM) dressing on bone exposed scalp wounds in the outpatient setting
M. Yudo, I. Prasidha, N. Osborne, S. Coburn, E. Fikri, D. Coker, R. Saw
Research Priorities from a repeat Melanoma Community Consultation - past and present
K. Winch, J. Kirkland, J. McNamara, K. Barnes-Cullen, S. Mailer, T. Lewin, G. McArthur
EGFR as a Predictive Biomarker for αCTLA4/αPD1 Sensitivity in BRAFi/MEKi resistant Melanoma
R. Patel, R. Saleh, A. Trigos, N. Haynes, G. McArthur
The conference was hosted by Melanoma Institute Australia – a non-profit organisation dedicated to preventing and curing melanoma through innovative, world-class research, treatment and education programs.
Our mission is zero deaths from melanoma this decade.
Melanoma Institute Australia
The Poche Centre, 40 Rocklands Rd, Wollstonecraft NSW 2065 Australia
Email: amc2024@melanoma.org.au Phone: +61 2 9911 7200
bottom of page